Fraudsters succeed when they learn and adapt faster than organizations can respond. Insights from one fraud scheme can inform the next, enabling sophisticated networks to change tactics quickly while the controls designed to stop them can take months or years to update.1 The cost can be enormous: The US Government Accountability Office estimated annual federal fraud losses of $233 billion to $521 billion between fiscal years 2018 and 2022.2
For federal and state health agencies, building a resilient fraud defense means more than detecting fraud. Agency reviewers and investigators work alongside oversight and law enforcement partners to protect patients, reduce burdens on compliant providers, and preserve program resources for the people and purposes they’re intended to serve. They also assess which potential fraud signals warrant review, what evidence is needed to pursue a lead, and how applicable policy and authority can inform response.
In practice, fraud control is often reactive: Pay the claim, detect the anomaly, investigate the lead, and try to recover the loss. But what if government could learn and adapt as quickly as fraudsters?
Agentic artificial intelligence, or agentic AI, offers a potential path forward toward more proactive fraud detection. Agency reviewers and investigators could use agentic AI systems not only to accelerate investigations, but also to help identify policy vulnerabilities before they’re exploited, flag emerging risks early, and learn from investigation outcomes. Over time, this approach could shift more fraud-fighting activity from recovery to prevention.
Agentic AI refers to systems that can help accomplish specific goals by planning and carrying out multistep tasks with limited supervision, within defined guardrails and under human oversight. In fraud control, agentic AI builds on predictive analytics, which typically estimates risk or flags anomalies, by organizing and contextualizing those signals for reviewers. An agentic AI system could gather evidence from multiple sources, evaluate it against program rules and policies, suggest next steps, and capture outcomes to inform future analyses. Agency reviewer and investigator judgment remains essential in every fraud assessment (figure 1).
Agentic AI has the potential to reshape how health agencies approach fraud detection and prevention. The following three capabilities illustrate where it could have the greatest operational impact.
Fraud investigations often begin after an agency has already made payments or incurred losses.3 Agency reviewers and investigators may identify suspicious behavior months or even years after a provider enrolls, changes ownership, begins billing, or exploits a policy vulnerability.4 As agentic AI systems detect fraud, they provide insights that can help inform an agency’s decisions to safeguard against new and evolving threats.
Agentic AI systems could test the strengths and vulnerabilities of new policies to help agencies make informed decisions on payment models. By simulating how different actors might respond to proposed rules, AI agents could help surface unintended incentives or administrative weaknesses and recommend alternative approaches that achieve the same policy objectives with lower fraud risk. That makes it easier to embed fraud risk assessment into the design of legislation, regulations, and sub-regulatory guidance before vulnerabilities are locked in.
Fraud risks can increase when policy or regulatory requirements are unclear.5 Even when policies are clear, complex rules and requirements can be challenging to apply in practice, particularly when managing multiple, conflicting policies.
AI agents could help by tracking policies across programs and surfacing conflicting rules for agencies to review. Health agencies can then systematize that knowledge and clarify rules through usable formats like checklists. Where requirements are ambiguous or conflicting, AI agents could flag the gaps and suggest options to fix them, which might save costs in the long run (figure 2). All AI agent suggestions should be verified by agency reviewers and investigators.
Enrollment reviews help prevent bad actors from entering programs, but risk doesn’t end once a provider is approved. Ownership changes, licenses expire, billing patterns shift, and new connections can emerge between providers and sanctioned entities.
AI monitoring agents could flag those changes as they happen, and support an auditable record. This would enable health agencies to intervene sooner rather than waiting to catch those leads at the next revalidation, which may be two to five years away.6
Agencies often have to compile evidence across fragmented systems before they can evaluate a potential fraud leads, requiring extensive time and attention. Automating much of that preparation can help staff spend more time on judgment and less on information gathering.
Bringing together information from multiple sources, AI agents could help compare findings against program rules, identify inconsistencies, and produce concise summaries for review. A consolidated evidence package can then help investigators spot high-risk leads that claims or transaction data alone may miss.
For example, AI agents could scan online reviews as signals of whether a provider is still operating and cross-check multiple sources to verify license status, saving reviewers time. As AI agents continuously scan provider data, agencies could maintain a living risk profile rather than a static file (see “Fight fraud smarter with a continuously-learning fraud defense”).
This also changes how agencies prioritize work. Instead of relying only on predefined risk scores and referrals, agentic AI could help improve this process by evaluating each lead against policy requirements, available evidence, and likely impact. That helps enable health agencies to focus on actionable leads where evidence is strong, the basis for agency action is clear, and potential for patient harm due to benefit changes is low and can be assessed and managed (figure 3).
Agency reviewers and investigators have long had access to sophisticated analytics, but those tools rely on predefined search terms, which can make it harder to flag anomalous billing patterns, limiting the ability to query freely, test new hypotheses, or look for repeat fraud patterns. With agentic AI systems, staff could ask plain-language questions that combine provider characteristics, program rules, network relationships, and fraud signals. This could help identify repeat fraud patterns. For example, an agency reviewer might ask an AI agent to flag every provider who lost an appeal, has been removed from a healthcare program, or had funds recovered.
The shift from searching for long-understood patterns to uncovering ones never before queried could help detection keep pace with fraud that constantly evolves. The same approach could support faster action across related leads.
Detecting fraud earlier and investigating it faster matter, but the bigger gains may come from helping agencies learn across programs and over time.
To identify fraud patterns across programs, agencies need consistent mechanisms to adjudicate shared signals, determine appropriate actions, and coordinate responses. Doing so requires clear authority, repeatable processes, and trust frameworks that enable agencies to share and act on information responsibly. Where secure sharing is possible, agentic AI could help synthesize signals across sources, identify related investigations, and surface risks that may not be visible within any single program.
Privacy-preserving approaches can help agencies learn from shared fraud patterns without centralizing sensitive data. A similar approach has shown promise in the private sector: The Society for Worldwide Interbank Financial Telecommunication used AI on cross-border payment fraud data from 13 financial institutions, resulting in a twofold improvement in detection of known fraud while keeping each institution’s data secured in-house.7
And even when full data integration isn’t feasible, agencies can still share risk signals and outcomes. The goal is not simply to move more data around; it’s to create a shared learning layer that enables one program’s signal, action, or result to help improve another program’s prevention efforts.
Health agencies could use agentic AI to support a continuous learning loop. This process can bring together fraud signals across the ecosystem, compare them with current policies and controls, and continuously update a multidimensional risk profile for each provider. Since the most useful signals often sit outside claims data, integrating these sources can reveal patterns that would otherwise be difficult to detect. As new signals arrive, the risk profile evolves, which could help agencies surface emerging schemes earlier and identify where interventions are working or falling short. Results from interventions can feed back into the process, informing real-time adjustments to operations, policies, and prevention and detection strategies.
The prevention payoff is straightforward: As agencies validate and incorporate pattern knowledge over time, they could use agentic AI systems to help identify emerging fraud schemes before they fully materialize and potentially prevent losses. Sharing these insights across agencies can strengthen fraud defenses over time. A signal in one program can become context for another, and an outcome in one jurisdiction can sharpen risk prevention and detection elsewhere (figure 4).
Responsible use of agentic AI requires strong guardrails: Systems should be secure, privacy-preserving, transparent, explainable, fair, accountable, and reliable. Human review of AI-generated fraud leads, with governance and validation, can provide feedback that can help the system distinguish likely fraud from legitimate variation, and may improve lead prioritization over time. Each risk should be managed with an appropriate safeguard (figure 5).
Human judgment, strong safeguards, and iterative testing are given. Beyond those, three conditions matter most.
Agentic AI can’t eliminate healthcare fraud, but it could help agencies stay ahead of it. By combining human judgment with systems that continuously learn across programs—from policy design and enrollment to review and investigation—health agencies could spot vulnerabilities earlier, investigate faster, and strengthen fraud defenses.
As adoption accelerates across the public sector, health agencies could lead the next wave of innovation in fraud prevention. The result might just be a fundamental shift from recovering losses to preventing fraud by design.